For the year ending 2025-12-31, BHIC made $5,688,717 in revenue. $642,090 in net income. Net profit margin of 11.29%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenues | 5,688,717 | |||
| Cost of goods sold | 2,448,000 | |||
| Gross profit | 3,240,717 | |||
| General and administrative expenses | 2,206,495 | |||
| Consulting fees | 315,171 | |||
| Total operating expenses | 2,521,666 | |||
| Income (loss) from operations | 719,051 | |||
| Income tax expense | 76,961 | |||
| Net income (loss) | 642,090 | |||
| Basic EPS | 0.06 | |||
| Diluted EPS | 0.06 | |||
| Basic Average Shares | 10,979,058 | |||
| Diluted Average Shares | 11,399,058 | |||
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)